Nasal spray for flu prevention shows promising trial results
February 5, 2026
Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials.
Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials.
OKLAHOMA CITY, Feb. 4, 2026 /PRNewswire/ — Acarix today announced its CADScor®System has successfully achieved certification under the European Union Medical Device Regulation (EU MDR 2017/745).
Dexcom (NSDQ:DXCM) announced today that it plans to launch an advanced AI-enabled enhancement to its Stelo over-the-counter CGM.
For the first time, the new scope allowed physicists to observe terahertz “jiggles” in a superconducting fluid.
Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician.
A University of Missouri researcher has unveiled a safer, smarter way to fight drug-resistant infections.
A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes.
An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and cheaper than before
I still vividly remember the first time we observed neurons responding not to audible sound, but to concentrated, precisely calibrated ultrasonic pulses.
A patient with complete blindness caused by irreversible optic nerve damage partially recovered natural vision after participating in a clinical trial of electrical stimulation of the visual cortex conducted by researchers.